Article Text

Download PDFPDF

Adoptive cellular gene therapy of autoimmune arthritis using a combination of lentivirally transduced dendritic cells
Free
  1. U Purath,
  2. R J Creusot,
  3. C Garrison Fathman,
  4. U Müller-Ladner,
  5. E Neumann,
  6. I H Tarner
  1. Department of Internal Medicine and Rheumatology, Justus-Liebig-University Giessen, Division of Rheumatology and Clinical Immunology, Kerckhoff-Klinik, Bad Nauheim, Germany

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Purpose

In order to minimise systemic side effects of immune-modulating therapy in rheumatoid arthritis (RA), local delivery of anti-inflammatory molecules to the inflamed joints would be desirable. Immune cells are promising vehicle cells for site-specific gene transfer because of their ability to migrate into inflamed tissues such as arthritic joints. In previous studies we have shown that gene transfer of single anti-inflammatory molecules by genetically modified lymphocytes prevents the onset of arthritis in collagen-induced arthritis (CIA) but does not ameliorate established disease …

View Full Text